One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration

Figure 2

Changes in mean central macular thickness (CMT). (a) Mean CMT of all 38 patients in three GLD groups; GLD ≦ 1800 μm, GLD between 1801 and 3500 μm, and GLD between 3501 and 5400 μm. All 3 groups showed similar values among the 3 groups at all time points. (b) Mean CMT of typical AMD of 24 patients. (c) Mean CMT of PCV of 14 patients in 3 GLD groups. There was no significant difference among the three groups (𝑃>0.05). Bars indicate standard deviations. *𝑃<0.05, **𝑃<0.01; 𝑃 value for comparison between baseline and each visit. AMD: age-related macular degeneration, GLD: greatest linear dimension. PCV: polypoidal choroidal vasculopathy.

(a)

(b)

(c)